Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Positive Data from Optimer
Yahoo/Zacks.com
Monday, April 12, 2010 - 9:39am
tags:
Optimer, fidaxomicin, Sanofi, ViroPharma
Nycomed Still Plans IPO
WSJ Online
Monday, April 12, 2010 - 9:38am
tags:
IPOs, Nycomed, Daxas, Forest Labs
Lilly’s Once-Weekly Byetta May Have Cancer Risk
Pharmalot
Monday, April 12, 2010 - 9:37am
tags:
Eli Lilly, Byetta, diabetes, cancer
Sanofi-Aventis Places Large Bet on Diabetes Drug Candidate
Seeking Alpha
Monday, April 12, 2010 - 9:06am
tags:
diabetes, Novo Nordisk, Sanofi, Pancreate, CureDM
Keryx Biopharmaceuticals Could Easily Triple Within the Next Year
Seeking Alpha
Monday, April 12, 2010 - 9:04am
tags:
Dendreon, Keryx, Merck, Pfizer, Ranbaxy, Sanofi
Tongjitang Receives Buyout Offer From CEO and Fosun
Seeking Alpha
Sunday, April 11, 2010 - 12:46pm
tags:
Tongjitang, Fosun Pharmaceutical
Onyx Scientific Grows API GMP Synthesis Contract Chemistry Services
PR-USA
Sunday, April 11, 2010 - 12:44pm
tags:
ONYX Pharmaceuticals
Tengion's IPO Comes In Well Below Initial Range: Biotech's Latest Deals, Financings
Seeking Alpha
Sunday, April 11, 2010 - 11:58am
tags:
Tengion, IPOs, Kips Bay Medical, Codexis, DynaVox, Alimera, Neovacs, Achoagen, Biocartis, Altheos, Sagent Pharmaceuticals, MicuRx Pharmaceuticals
CureDM Partners Novel Diabetes Treatment With Sanofi-Aventis
Medical News Today
Sunday, April 11, 2010 - 11:41am
tags:
CureDM, Sanofi, diabetes, Pancreate
Drug giants tackle 'neglected' effort
San Diego Union Tribune, CA
Sunday, April 11, 2010 - 11:36am
tags:
orphan drugs, Novartis
Mylan Receives Approval for Generic Version of NuLytely
PR-Canada
Sunday, April 11, 2010 - 11:32am
tags:
Mylan, NuLytely, laxatives
Positive Results from Optimer Pharmaceuticals' Second Phase 3 Study of Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI) Presented at ECCMID
Yahoo/PR NewsWire
Sunday, April 11, 2010 - 11:30am
tags:
Optimer, fidaxomicin, Clostridium Difficile
Most Active Biotech Stocks (SNSS, CTIC, ANX, AMGN, CELG)
EarthTimes
Saturday, April 10, 2010 - 1:17pm
tags:
biotech, investors
Cannasat Therapeutics Announces Private Placement
PR-USA
Saturday, April 10, 2010 - 1:14pm
tags:
Cannasat Therapeutics, Parkinson's Disease, neuropathic pain
Indian Pharmaceutical 4Q FY2010 outlook
Stock Markets Review
Saturday, April 10, 2010 - 1:00pm
tags:
India
Cool Tools for Biotech
Barron's
Saturday, April 10, 2010 - 12:57pm
tags:
Bruker, biotech
Sun Pharma announces USFDA tentative approval for generic Namenda(R) tablets
MarketWatch
Saturday, April 10, 2010 - 12:56pm
tags:
Sun Pharma, Namenda, Alzheimer's disease
Aeterna Zentaris Announces Initiation Of Phase 3 Registration Trial With Perifosine In Refractory Advanced Colorectal Cancer
Medical News Today
Saturday, April 10, 2010 - 12:53pm
tags:
Aeterna Zentaris, colorectal cancer, perifosine
Radient Pharmaceuticals Extends Onko-Sure Cancer Test Distribution Partnership for the Market of India
PR-USA
Saturday, April 10, 2010 - 12:51pm
tags:
Radient Pharmaceuticals, oncology
One-off treatment 'could switch off rheumatoid arthritis'
Telegraph, UK
Saturday, April 10, 2010 - 12:49pm
tags:
rheumatoid arthritis, GSK, otelixizumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.